OmotayoFasanMDMRCP

PubMed

• 2 citations
  Cost saving, patient centered algorithm for progenitor cell mobilization for autologous hematopoietic cell transplantation.
  Srinivasa R. Sanikommu, Emily S. Reese, Jiaxian He, Carlos Lee, Jing Ai, Candace Butler, Ryan Jacobs, Bei Hu, Shebli Atrash, Jigar Trivedi, Manisha Bhutani, Peter M. V...> ;Journal of Clinical Apheresis. 2021 Mar 12
• 4 citations
  Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia.
  Omotayo Fasan> ;Current Opinion in Hematology. 2019 Nov 1
• 76 citations
  ALK Fusions in a Wide Variety of Tumor Types Respond to Anti‐ALK Targeted Therapy
  Jeffrey S. Ross, Siraj M. Ali, Omotayo Fasan, Jared Block, Sumanta K. Pal, Julia A. Elvin, Alexa B. Schrock, James Suh, Sahar Nozad, Sungeun Kim, Hwajeong Lee, Christi...> ;The Oncologist. 2017 Dec 1
• 218 citations
  Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant C...
  Asad Bashey, Mei-Jie Zhang, Shannon R. McCurdy, Andrew St. Martin, Trevor Argall, Claudio Anasetti, Stefan O. Ciurea, Omotayo Fasan, Sameh Gaballa, Mehdi Hamadani, Pas...> ;Journal of Clinical Oncology. 2017 Jun 23
• 51 citations
  Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome
  Brian C. Shaffer, Martin S. Tallman, Adriana K. Malone, Ran Reshef, Mark R. Litzow, Jane L. Liesveld, Peter H. Wiernik, Kwang Woo Ahn, Zhen-Huan Hu, Wael Saber, Taiga ...> ;Journal of Clinical Oncology. 2016 Sep 27
• 296 citations
  Diverse and Targetable Kinase Alterations Drive Histiocytic Neoplasms
  Eli L. Diamond, Benjamin H. Durham, Julien Haroche, Zhan Yao, Jing Ma, Sameer A. Parikh, Zhaoming Wang, John K. Choi, Eunhee Kim, Fleur Cohen-Aubart, Stanley Chun-Wei ...> ;Cancer Discovery. 2016 Feb 1
• 26 citations
  Expanding role of lenalidomide in hematologic malignancies.
  Nilanjan Ghosh, Michael R. Grunwald, Omotayo Fasan, Manisha Bhutani> ;Cancer Management and Research. 2015 May 2
• 7 citations
  Comparison of Outcomes of Allogeneic Transplantation for Chronic Myeloid Leukemia with Cyclophosphamide in Combination with Intravenous Busulfan, Oral Busulfan, or Tot...
  Edward A. Copelan, Belinda R. Avalos, Kwang Woo Ahn, Xiaochun Zhu, Robert Peter Gale, Michael R. Grunwald, Mehdi Hamadani, Betty K. Hamilton, Gregory A. Hale, David I....> ;Biology of Blood and Marrow Transplantation. 2015 Mar 1
• Optimal autologous peripheral blood progenitor cell mobilization involves more than the CD34+yield.
  Omotayo Fasan> ;Biology of Blood and Marrow Transplantation. 2014 Jan 1
• 32 citations
  Plasmacytic post-transplant lymphoproliferative disorder: a case series of nine patients.
  Meghan Karuturi, Nirav N. Shah, Dale Frank, Omotayo Fasan, Ran Reshef, Vivek N. Ahya, Michael Bromberg, Thomas W. Faust, Simin Goral, Stephen J. Schuster, Edward A. St...> ;Transplant International. 2013 Jun 1
• 24 citations
  Thrombolysis in pregnancy.
  Raj K. Patel, Omotayo Fasan, Roopen Arya> ;Thrombosis and Haemostasis. 2003 Dec 1
• 7 citations
  Epstein-Barr virus-related post-transplant lymphoproliferative disorder with t(9;14)(p11-12;q32).
  Omotayo Fasan, C. Willmott, B. Czepulkowski, A. Baker, David C. Rees, Jonathan R. Salisbury, Ghulam J. Mufti> ;Cancer Genetics and Cytogenetics. 2003 Apr 15
• Join now to see all